Medicine Overview of Olmecip Trio Tablet
Nausea, Altered taste, Stomach upset, Diarrhoea, Headache, Dizziness, Weakness, Electrolyte imbalance, Glucose intolerance, Increased blood lipid level, Increased blood uric acid, Decreased blood pressure.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Olmecip Trio 12.5 mg/20 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Olmecip Trio 12.5 mg/20 mg Tablet is a combination of two medicines: Hydrochlorothiazide and olmesartan which lower blood pressure effectively. Hydrochlorothiazide is a diuretic that removes extra water and certain electrolytes from the body. Over time it also relaxes blood vessels and improves blood flow. Olmesartan is an angiotensin receptor blocker (ARB). It works by blocking the hormone angiotensin thereby relaxing blood vessels. This allows the blood to flow more smoothly and the heart to pump more efficiently.
In Depth Information on Olmecip Trio Tablet
Olmecip Trio Tablet related warnings
Taking Olmesartan with alcohol may excessively lower the blood pressure.
WEIGH RISKS VS BENEFITS
Olmecip Trio 12.5 mg/20 mg Tablet is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Olmecip Trio 12.5 mg/20 mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Olmecip Trio 12.5 mg/20 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Olmecip Trio 12.5 mg/20 mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Olmecip Trio 12.5 mg/20 mg Tablet may be needed. Please consult your doctor.
Regular monitoring of blood pressure is advisable for dose adjustment.
Olmecip Trio 12.5 mg/20 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Olmecip Trio 12.5 mg/20 mg Tablet may be needed. Please consult your doctor.
No Patient Concerns found for this medicine
User Submitted Feedback For Olmecip Trio 12.5 mg/20 mg Tablet
Patients taking Olmecip Trio 12.5 mg/20 mg Tablet What are you using Olmecip Trio Tablet for?
Survey Participants: 2
“The following are the results of on-going survey on 1mg.com for Olmecip Trio 12.5 mg/20 mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Olmecip Trio 12.5 mg/20 mg Tablet: FGH, BDN, RHW, ABP, NDP, GTC, SWP, DFP, BBS, PWN, SHD, MAX, BMJ, NTB, SGC, VRS, BHP, KHH, NSL, AAY, BIO, CLT, ADT, MLC, RSA, PTI, HAT, EMB, SHP, PNT, SRG, 9T9, MSD, RJH, WSI, MDO, NVL, GBL, SBL, MAK, TRP, PEN, BSN, RHL, RSS, PVP, DGN, RKS, EQN, BAL, ZVP, OLT, JMJ, ATP, DPP, SBA, PPR, MAM, MPC, INC, SAF, OWP, SVH, ZEL, AYU, HIP, TOM, SJP, USF, THP, GNC, HPC, ANT, AVN, IAD, SDM, TNH, MOM, GTK, SCH, SSA, ARD, DHR, OIP, JIV, SYN, STA, ENP, RUS, GPT, WHL, MMS, UMP, IPL, RWP, DYG, PLT, SAT, HGI, HMP, NVY, HEX, SWA, DPL, JVO, BTM, NNH, DLP, RPP, DDR, AMR, NWP, OHM, ATL, LCC, LHA, HBV, PRN, NXG, AGT, AAR, JVN, GPP